To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal Women

ClinicalTrials.gov ID: NCT00145275

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00145275. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Zoledronic acid is a medicine being studied in people with low bone mass. Side effects such as headache, fever, muscle aches, and pains, may occur following the infusion. This study will investigate the use of over-the-counter medicines to improve these symptoms.

Study identification

NCT ID: NCT00145275
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Novartis; Industry
Enrollment: 455 participants

Conditions and interventions

Conditions

Osteopenia

Interventions

zoledronic acid Drug

Drug

Eligibility (public fields only)

Age range: 45 Years to 75 Years
Sex: Female
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 2004 (Type not available)
Primary completion: Oct 2005 (Actual)
Completion: Oct 2005 (Actual)
Last update posted: Apr 27, 2012

2004 – 2005

United States locations

U.S. sites: 6
U.S. states: 6
U.S. cities: 6

Facility	City	State	ZIP	Site status
Not listed	Unavailable	Georgia	—	—
Not listed	Unavailable	Illinois	—	—
Not listed	Unavailable	Indiana	—	—
Not listed	Unavailable	Iowa	—	—
Not listed	Unavailable	Kansas	—	—
Not listed	Unavailable	Washington	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00145275, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 27, 2012 · Synced Nov 15, 2026